ArticleLiver international : official journal of the International Association for the Study of the Liver2025

Gut Microbiota Predicts Treatment Response to Empagliflozin Among MASLD Patients Without Diabetes Mellitus.

Ho Yu Ng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.